Celldex Therapeutics (CLDX) Return on Capital Employed [ROCE] (2011 - 2026)
Celldex Therapeutics (CLDX) reported Return on Capital Employed [ROCE] of -55.65% for Q2 2026, down 21.28 percentage points from -34.37% a year earlier but up 6.70 percentage points from the prior quarter.
Powered by 
Analysis
Celldex Therapeutics (CLDX) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends
For FY2025, Celldex Therapeutics posted Return on Capital Employed [ROCE] of -45.14%, down 12.04 percentage points from FY2024.
- Return on Capital Employed [ROCE] has a five-year change of -6.78 percentage points (FY2020 to FY2025).
- By year, Return on Capital Employed [ROCE] came in at -33.09% in FY2024 (+7.78 pp), -40.88% in FY2023 (-10.56 pp), -30.32% in FY2022 (-8.31 pp) and -22.01% in FY2021 (+16.35 pp).
- Five-year quarterly Return on Capital Employed [ROCE] spans a low of -62.36% in Q1 2026 and a high of -16.34% in Q4 2021.
- Year over year, Return on Capital Employed [ROCE] has now declined in each of the last six quarters, with an average year-over-year change of -8.34 percentage points over the last eight quarters.
- The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q3 2024 (a gain of 28.19 percentage points); the low point was Q1 2026 (a drop of 32.76 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -62.36% (Q1 2026), -50.89% (Q4 2025) and -41.07% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 11.86% |
| 10 | Celldex Therapeutics | 2.53 Bn | 2.53 Bn | - | -55.65% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -55.65% |
| Mar 31, 2026 | -62.36% |
| Dec 31, 2025 | -50.89% |
| Sep 30, 2025 | -41.07% |
| Jun 30, 2025 | -34.37% |
| Mar 31, 2025 | -29.60% |
| Dec 31, 2024 | -25.39% |
| Sep 30, 2024 | -23.27% |
| Jun 30, 2024 | -21.19% |
| Mar 31, 2024 | -25.38% |
| Dec 31, 2023 | -45.21% |
| Sep 30, 2023 | -51.46% |
| Jun 30, 2023 | -40.93% |
| Mar 31, 2023 | -38.48% |
| Dec 31, 2022 | -33.66% |
| Sep 30, 2022 | -29.12% |
| Jun 30, 2022 | -26.29% |
| Mar 31, 2022 | -18.55% |
| Dec 31, 2021 | -16.34% |
| Sep 30, 2021 | -23.79% |
API Access
Celldex Therapeutics Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CLDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "CLDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CLDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();